John Kappler
Concepts (933)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| T-Lymphocytes | 239 | 2021 | 1993 | 6.330 |
Why?
| | Receptors, Antigen, T-Cell | 125 | 2024 | 718 | 5.810 |
Why?
| | Histocompatibility Antigens Class II | 80 | 2021 | 368 | 5.620 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 64 | 2024 | 337 | 5.140 |
Why?
| | CD4-Positive T-Lymphocytes | 55 | 2024 | 1095 | 4.180 |
Why?
| | Major Histocompatibility Complex | 56 | 2024 | 227 | 3.870 |
Why?
| | Thymus Gland | 59 | 2024 | 313 | 2.730 |
Why?
| | Peptide Fragments | 24 | 2021 | 705 | 2.570 |
Why?
| | Peptides | 48 | 2021 | 980 | 2.550 |
Why?
| | Hybridomas | 74 | 2019 | 237 | 2.430 |
Why?
| | Lymphocyte Activation | 81 | 2020 | 1150 | 2.160 |
Why?
| | Antigens | 50 | 2021 | 358 | 1.980 |
Why?
| | Mice | 331 | 2024 | 17757 | 1.870 |
Why?
| | Histocompatibility Antigens | 17 | 2019 | 105 | 1.850 |
Why?
| | Epitopes, T-Lymphocyte | 9 | 2021 | 187 | 1.730 |
Why?
| | H-2 Antigens | 38 | 2011 | 115 | 1.610 |
Why?
| | B-Lymphocytes | 61 | 2017 | 846 | 1.600 |
Why?
| | Animals | 371 | 2024 | 36847 | 1.580 |
Why?
| | Autoantigens | 23 | 2021 | 428 | 1.450 |
Why?
| | Amino Acid Sequence | 72 | 2019 | 2138 | 1.410 |
Why?
| | Autoimmunity | 13 | 2021 | 908 | 1.370 |
Why?
| | Epitopes | 47 | 2021 | 480 | 1.370 |
Why?
| | Berylliosis | 10 | 2021 | 186 | 1.320 |
Why?
| | Molecular Sequence Data | 68 | 2015 | 2894 | 1.170 |
Why?
| | Protein Binding | 36 | 2021 | 2216 | 1.160 |
Why?
| | Enterotoxins | 26 | 2009 | 87 | 1.160 |
Why?
| | Autoimmune Diseases | 7 | 2021 | 460 | 1.140 |
Why?
| | Models, Molecular | 29 | 2018 | 1570 | 1.140 |
Why?
| | Antigen Presentation | 17 | 2021 | 216 | 1.140 |
Why?
| | Immune Tolerance | 31 | 2024 | 362 | 1.130 |
Why?
| | Histocompatibility Antigens Class I | 12 | 2018 | 202 | 1.040 |
Why?
| | Diabetes Mellitus, Type 1 | 16 | 2021 | 3710 | 1.010 |
Why?
| | Immunologic Memory | 26 | 2020 | 370 | 1.000 |
Why?
| | Beryllium | 8 | 2021 | 153 | 0.990 |
Why?
| | Antibodies, Monoclonal | 55 | 2020 | 1430 | 0.970 |
Why?
| | Baculoviridae | 9 | 2015 | 44 | 0.960 |
Why?
| | HLA-DP beta-Chains | 10 | 2021 | 86 | 0.930 |
Why?
| | Alleles | 13 | 2017 | 890 | 0.920 |
Why?
| | Insulin | 11 | 2024 | 2406 | 0.910 |
Why?
| | CD8-Positive T-Lymphocytes | 24 | 2021 | 913 | 0.900 |
Why?
| | Interleukin-2 | 37 | 2015 | 455 | 0.840 |
Why?
| | Superantigens | 18 | 2002 | 70 | 0.820 |
Why?
| | Mice, Inbred C57BL | 102 | 2024 | 5749 | 0.770 |
Why?
| | Antigens, Surface | 24 | 2011 | 153 | 0.760 |
Why?
| | Mice, Transgenic | 48 | 2024 | 2163 | 0.740 |
Why?
| | Cathepsins | 1 | 2021 | 24 | 0.710 |
Why?
| | Lysosomes | 2 | 2021 | 141 | 0.710 |
Why?
| | Cell Line | 41 | 2021 | 2838 | 0.700 |
Why?
| | HLA-DR Antigens | 9 | 2016 | 228 | 0.690 |
Why?
| | Peptide Library | 6 | 2013 | 88 | 0.670 |
Why?
| | T-Lymphocyte Subsets | 19 | 2013 | 425 | 0.660 |
Why?
| | Adjuvants, Immunologic | 12 | 2016 | 226 | 0.660 |
Why?
| | Protein Conformation | 21 | 2018 | 933 | 0.660 |
Why?
| | Antigens, Neoplasm | 8 | 2021 | 319 | 0.650 |
Why?
| | Flow Cytometry | 28 | 2015 | 1180 | 0.630 |
Why?
| | Islets of Langerhans | 4 | 2021 | 803 | 0.620 |
Why?
| | Immunoglobulin G | 10 | 2017 | 887 | 0.600 |
Why?
| | Genes, MHC Class II | 18 | 2014 | 74 | 0.600 |
Why?
| | Base Sequence | 36 | 2016 | 2179 | 0.590 |
Why?
| | Mammary Tumor Virus, Mouse | 12 | 1995 | 44 | 0.580 |
Why?
| | Chromogranin A | 2 | 2015 | 42 | 0.550 |
Why?
| | Amino Acids | 5 | 2022 | 497 | 0.530 |
Why?
| | Binding Sites | 20 | 2021 | 1301 | 0.530 |
Why?
| | Mice, Inbred BALB C | 48 | 2021 | 1269 | 0.530 |
Why?
| | Membrane Proteins | 14 | 2020 | 1163 | 0.530 |
Why?
| | Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 4 | 2012 | 27 | 0.520 |
Why?
| | Mice, Inbred NOD | 11 | 2020 | 600 | 0.510 |
Why?
| | Ikaros Transcription Factor | 2 | 2013 | 24 | 0.500 |
Why?
| | Antigen-Presenting Cells | 21 | 2015 | 156 | 0.490 |
Why?
| | Lymphocyte Cooperation | 21 | 1990 | 49 | 0.490 |
Why?
| | Complementarity Determining Regions | 8 | 2012 | 51 | 0.480 |
Why?
| | Proto-Oncogene Proteins | 12 | 2009 | 647 | 0.480 |
Why?
| | Immunity, Cellular | 16 | 2010 | 268 | 0.470 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 12 | 2007 | 233 | 0.470 |
Why?
| | CD3 Complex | 10 | 2018 | 106 | 0.470 |
Why?
| | Alum Compounds | 6 | 2016 | 22 | 0.470 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 1 | 2015 | 86 | 0.470 |
Why?
| | Hypersensitivity | 3 | 2016 | 257 | 0.460 |
Why?
| | Evolution, Molecular | 4 | 2019 | 488 | 0.450 |
Why?
| | Histone Demethylases | 3 | 2020 | 32 | 0.450 |
Why?
| | Antigens, Differentiation, T-Lymphocyte | 18 | 1991 | 98 | 0.440 |
Why?
| | bcl-2-Associated X Protein | 4 | 2006 | 56 | 0.440 |
Why?
| | Immunoglobulin Variable Region | 11 | 2012 | 80 | 0.430 |
Why?
| | Gene Expression Regulation | 22 | 2015 | 2605 | 0.430 |
Why?
| | Thymoma | 5 | 2012 | 36 | 0.430 |
Why?
| | Antibody Formation | 21 | 2010 | 298 | 0.420 |
Why?
| | Mice, Inbred Strains | 36 | 2000 | 409 | 0.420 |
Why?
| | Mutation | 25 | 2022 | 3946 | 0.420 |
Why?
| | Conserved Sequence | 3 | 2009 | 239 | 0.410 |
Why?
| | Lymphocytes, Null | 1 | 2012 | 3 | 0.410 |
Why?
| | Spleen | 32 | 2016 | 514 | 0.410 |
Why?
| | Apoptosis | 15 | 2011 | 2551 | 0.410 |
Why?
| | Lymphokines | 12 | 1984 | 131 | 0.400 |
Why?
| | HLA-DR4 Antigen | 2 | 2005 | 78 | 0.400 |
Why?
| | Bacterial Toxins | 6 | 1997 | 105 | 0.400 |
Why?
| | Antigens, Viral | 10 | 2001 | 181 | 0.390 |
Why?
| | Crystallography, X-Ray | 10 | 2018 | 476 | 0.390 |
Why?
| | Protein Processing, Post-Translational | 8 | 2018 | 465 | 0.390 |
Why?
| | Apoptosis Regulatory Proteins | 10 | 2011 | 188 | 0.380 |
Why?
| | Spike Glycoprotein, Coronavirus | 3 | 2022 | 108 | 0.380 |
Why?
| | Ligands | 13 | 2022 | 661 | 0.380 |
Why?
| | Protein Structure, Tertiary | 10 | 2021 | 860 | 0.380 |
Why?
| | Staphylococcus aureus | 12 | 1999 | 449 | 0.370 |
Why?
| | Glycoproteins | 3 | 2011 | 342 | 0.370 |
Why?
| | Humans | 130 | 2025 | 136769 | 0.370 |
Why?
| | Cancer Vaccines | 5 | 2021 | 172 | 0.350 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 3 | 2018 | 62 | 0.350 |
Why?
| | Antigens, Bacterial | 8 | 2013 | 129 | 0.350 |
Why?
| | Clone Cells | 22 | 2024 | 266 | 0.350 |
Why?
| | Toll-Like Receptor 7 | 4 | 2016 | 39 | 0.350 |
Why?
| | Cells, Cultured | 36 | 2021 | 4191 | 0.340 |
Why?
| | Interferon-gamma | 14 | 2016 | 789 | 0.340 |
Why?
| | B-Lymphocyte Subsets | 4 | 2020 | 75 | 0.340 |
Why?
| | Antibodies | 10 | 2009 | 411 | 0.340 |
Why?
| | Carrier Proteins | 10 | 2009 | 769 | 0.340 |
Why?
| | Cell Differentiation | 28 | 2021 | 1982 | 0.320 |
Why?
| | Proinsulin | 2 | 2021 | 52 | 0.310 |
Why?
| | Ovalbumin | 21 | 2011 | 183 | 0.300 |
Why?
| | Signal Transduction | 17 | 2016 | 5076 | 0.300 |
Why?
| | CD11c Antigen | 5 | 2020 | 41 | 0.290 |
Why?
| | Nickel | 2 | 2012 | 62 | 0.290 |
Why?
| | Immunotherapy | 5 | 2021 | 640 | 0.290 |
Why?
| | Cross Reactions | 10 | 2012 | 133 | 0.280 |
Why?
| | Gene Expression | 11 | 2017 | 1500 | 0.280 |
Why?
| | Amino Acid Motifs | 7 | 2019 | 225 | 0.280 |
Why?
| | HLA-DQ Antigens | 6 | 2019 | 181 | 0.280 |
Why?
| | Immunoglobulin Fab Fragments | 3 | 2006 | 59 | 0.280 |
Why?
| | Cytokines | 13 | 2020 | 2084 | 0.270 |
Why?
| | beta 2-Microglobulin | 4 | 2010 | 50 | 0.270 |
Why?
| | Arthritis, Rheumatoid | 5 | 2014 | 1167 | 0.270 |
Why?
| | Cytochrome c Group | 5 | 2002 | 43 | 0.260 |
Why?
| | Insecta | 4 | 2009 | 66 | 0.260 |
Why?
| | Histones | 4 | 2018 | 636 | 0.250 |
Why?
| | Dendritic Cells | 7 | 2013 | 484 | 0.250 |
Why?
| | Cell Proliferation | 10 | 2020 | 2475 | 0.240 |
Why?
| | Kinetics | 18 | 2021 | 1664 | 0.240 |
Why?
| | Lupus Erythematosus, Systemic | 3 | 2017 | 242 | 0.240 |
Why?
| | HLA-D Antigens | 3 | 1998 | 34 | 0.240 |
Why?
| | Cell Survival | 18 | 2009 | 1116 | 0.230 |
Why?
| | Eicosapentaenoic Acid | 1 | 2025 | 39 | 0.230 |
Why?
| | Staphylococcus | 5 | 1994 | 76 | 0.230 |
Why?
| | Transcription, Genetic | 8 | 2020 | 1455 | 0.230 |
Why?
| | Docosahexaenoic Acids | 1 | 2025 | 84 | 0.230 |
Why?
| | Interleukin-12 | 2 | 2016 | 121 | 0.220 |
Why?
| | Out-of-Hospital Cardiac Arrest | 1 | 2025 | 72 | 0.220 |
Why?
| | Protein Folding | 2 | 2021 | 280 | 0.220 |
Why?
| | Herpesviridae Infections | 2 | 2017 | 149 | 0.220 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2025 | 139 | 0.210 |
Why?
| | T-Lymphocytes, Helper-Inducer | 9 | 1989 | 137 | 0.210 |
Why?
| | Macromolecular Substances | 17 | 2003 | 229 | 0.210 |
Why?
| | Macrophages | 19 | 2011 | 1544 | 0.210 |
Why?
| | Surface Plasmon Resonance | 5 | 2021 | 87 | 0.210 |
Why?
| | Positive Transcriptional Elongation Factor B | 2 | 2020 | 29 | 0.210 |
Why?
| | T-Cell Antigen Receptor Specificity | 3 | 2011 | 51 | 0.200 |
Why?
| | DNA | 12 | 2016 | 1458 | 0.200 |
Why?
| | Mice, Knockout | 17 | 2024 | 3008 | 0.200 |
Why?
| | Germ Cells | 2 | 2016 | 63 | 0.200 |
Why?
| | Antiviral Agents | 2 | 2021 | 739 | 0.200 |
Why?
| | Concanavalin A | 18 | 1990 | 76 | 0.200 |
Why?
| | Receptors, Cell Surface | 3 | 2020 | 382 | 0.200 |
Why?
| | Lung | 7 | 2021 | 4062 | 0.200 |
Why?
| | T-Box Domain Proteins | 4 | 2020 | 98 | 0.200 |
Why?
| | Natural Killer T-Cells | 2 | 2013 | 67 | 0.200 |
Why?
| | Cell Death | 13 | 2006 | 372 | 0.190 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 10 | 2017 | 851 | 0.190 |
Why?
| | Vaccines, Subunit | 3 | 2012 | 49 | 0.190 |
Why?
| | Homeostasis | 5 | 2007 | 619 | 0.190 |
Why?
| | Neoplasms, Experimental | 3 | 2021 | 176 | 0.190 |
Why?
| | Neoplasms | 5 | 2021 | 2644 | 0.190 |
Why?
| | Oligonucleotide Array Sequence Analysis | 5 | 2008 | 766 | 0.190 |
Why?
| | Immune System | 5 | 2013 | 177 | 0.190 |
Why?
| | Transfection | 17 | 2009 | 941 | 0.190 |
Why?
| | Sequence Homology, Amino Acid | 6 | 2019 | 385 | 0.190 |
Why?
| | Structure-Activity Relationship | 10 | 2006 | 570 | 0.190 |
Why?
| | Recombinant Proteins | 7 | 2005 | 1350 | 0.180 |
Why?
| | Polymorphism, Genetic | 6 | 2012 | 659 | 0.180 |
Why?
| | Aging | 8 | 2015 | 1864 | 0.180 |
Why?
| | Crystallization | 2 | 2015 | 141 | 0.180 |
Why?
| | Peptidyl Transferases | 1 | 2021 | 8 | 0.180 |
Why?
| | Antibodies, Monoclonal, Humanized | 3 | 2022 | 801 | 0.180 |
Why?
| | Chemokine CCL3 | 1 | 2021 | 16 | 0.180 |
Why?
| | Chemokine CCL4 | 1 | 2021 | 23 | 0.180 |
Why?
| | Bcl-2-Like Protein 11 | 9 | 2009 | 38 | 0.180 |
Why?
| | Female | 73 | 2025 | 72796 | 0.180 |
Why?
| | Pancreas | 2 | 2021 | 329 | 0.180 |
Why?
| | Saccharomyces cerevisiae | 1 | 2005 | 556 | 0.180 |
Why?
| | HLA-C Antigens | 1 | 2021 | 35 | 0.180 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 9 | 2011 | 345 | 0.170 |
Why?
| | Cloning, Molecular | 12 | 2000 | 534 | 0.170 |
Why?
| | Autoantibodies | 6 | 2017 | 1496 | 0.170 |
Why?
| | Cyclin-Dependent Kinase 9 | 1 | 2020 | 10 | 0.170 |
Why?
| | Immunoglobulin Idiotypes | 6 | 1986 | 27 | 0.170 |
Why?
| | Epitope Mapping | 4 | 2015 | 62 | 0.170 |
Why?
| | Synovial Fluid | 2 | 2000 | 67 | 0.170 |
Why?
| | HLA-DP Antigens | 2 | 2010 | 33 | 0.170 |
Why?
| | RNA Polymerase II | 2 | 2020 | 324 | 0.170 |
Why?
| | Inflammation | 5 | 2020 | 2835 | 0.170 |
Why?
| | Substrate Specificity | 3 | 2017 | 371 | 0.160 |
Why?
| | Hemolytic Plaque Technique | 16 | 1983 | 29 | 0.160 |
Why?
| | Animal Fur | 1 | 2019 | 1 | 0.160 |
Why?
| | Haptens | 4 | 1988 | 22 | 0.160 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2020 | 655 | 0.160 |
Why?
| | Nerve Growth Factors | 1 | 2000 | 79 | 0.160 |
Why?
| | Glycosaminoglycans | 1 | 2000 | 83 | 0.160 |
Why?
| | Genes | 15 | 1990 | 230 | 0.160 |
Why?
| | CD8 Antigens | 9 | 2006 | 75 | 0.160 |
Why?
| | Alveolitis, Extrinsic Allergic | 1 | 2020 | 97 | 0.160 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 267 | 0.160 |
Why?
| | Minor Lymphocyte Stimulatory Antigens | 11 | 1993 | 22 | 0.160 |
Why?
| | Membrane Glycoproteins | 6 | 2013 | 500 | 0.160 |
Why?
| | Sarcoidosis, Pulmonary | 1 | 2020 | 83 | 0.160 |
Why?
| | Lipocalins | 1 | 2019 | 36 | 0.160 |
Why?
| | Cell Separation | 13 | 2014 | 317 | 0.160 |
Why?
| | DNA Mutational Analysis | 2 | 2009 | 399 | 0.160 |
Why?
| | Cell Line, Transformed | 2 | 2018 | 145 | 0.160 |
Why?
| | Methyltransferases | 1 | 2020 | 78 | 0.150 |
Why?
| | Mice, Inbred DBA | 20 | 2002 | 200 | 0.150 |
Why?
| | Lymph Nodes | 12 | 2013 | 492 | 0.150 |
Why?
| | Vaccines | 3 | 2016 | 405 | 0.150 |
Why?
| | Interleukin-4 | 6 | 2008 | 216 | 0.150 |
Why?
| | Disease Models, Animal | 7 | 2015 | 4282 | 0.150 |
Why?
| | HIV Envelope Protein gp120 | 1 | 1999 | 60 | 0.150 |
Why?
| | T-Lymphocytes, Regulatory | 4 | 2014 | 387 | 0.150 |
Why?
| | Protein Structure, Secondary | 5 | 2012 | 374 | 0.150 |
Why?
| | Molecular Weight | 12 | 2006 | 335 | 0.150 |
Why?
| | Genetic Linkage | 8 | 2002 | 297 | 0.150 |
Why?
| | Mice, Mutant Strains | 8 | 2014 | 298 | 0.150 |
Why?
| | Antibody Specificity | 11 | 2020 | 189 | 0.150 |
Why?
| | Cell Division | 12 | 2008 | 796 | 0.150 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2021 | 247 | 0.150 |
Why?
| | Species Specificity | 12 | 2006 | 586 | 0.150 |
Why?
| | Th2 Cells | 3 | 2010 | 176 | 0.140 |
Why?
| | Genome | 2 | 2000 | 294 | 0.140 |
Why?
| | Hybrid Cells | 4 | 1997 | 49 | 0.140 |
Why?
| | Antigens, Ly | 4 | 1988 | 44 | 0.140 |
Why?
| | Transcription Factors | 5 | 2024 | 1718 | 0.140 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 1 | 1998 | 101 | 0.140 |
Why?
| | Cell Line, Tumor | 6 | 2021 | 3405 | 0.140 |
Why?
| | bcl-X Protein | 4 | 2006 | 43 | 0.140 |
Why?
| | Hemocyanins | 9 | 1983 | 62 | 0.140 |
Why?
| | Vaccination | 8 | 2010 | 1377 | 0.140 |
Why?
| | Gene Expression Profiling | 5 | 2013 | 1772 | 0.140 |
Why?
| | Herpesviridae | 1 | 2017 | 22 | 0.140 |
Why?
| | Cat Diseases | 1 | 2017 | 21 | 0.140 |
Why?
| | Interleukin-7 | 4 | 2004 | 61 | 0.130 |
Why?
| | Erythrocytes | 25 | 2002 | 699 | 0.130 |
Why?
| | Spodoptera | 3 | 2021 | 40 | 0.130 |
Why?
| | Fluorescent Antibody Technique | 6 | 2011 | 388 | 0.130 |
Why?
| | Solubility | 5 | 2003 | 245 | 0.130 |
Why?
| | Cell Communication | 8 | 2013 | 315 | 0.130 |
Why?
| | Friend murine leukemia virus | 1 | 2016 | 30 | 0.130 |
Why?
| | Deoxyribonucleases | 1 | 2016 | 24 | 0.130 |
Why?
| | Antibody-Producing Cells | 11 | 1983 | 30 | 0.130 |
Why?
| | Germ-Line Mutation | 2 | 2009 | 172 | 0.130 |
Why?
| | Antibody Affinity | 4 | 2020 | 60 | 0.130 |
Why?
| | Ubiquitin-Protein Ligases | 2 | 2008 | 176 | 0.130 |
Why?
| | Allergens | 1 | 2019 | 408 | 0.130 |
Why?
| | Mice, Inbred AKR | 10 | 1989 | 35 | 0.130 |
Why?
| | Immunity | 3 | 2007 | 143 | 0.130 |
Why?
| | Thymocytes | 2 | 2013 | 35 | 0.120 |
Why?
| | Protein Precursors | 1 | 2016 | 132 | 0.120 |
Why?
| | Clonal Anergy | 3 | 2006 | 52 | 0.120 |
Why?
| | Immunologic Deficiency Syndromes | 3 | 2007 | 69 | 0.120 |
Why?
| | Binding, Competitive | 9 | 2010 | 202 | 0.120 |
Why?
| | Genetic Predisposition to Disease | 6 | 2021 | 2412 | 0.120 |
Why?
| | Methylation | 5 | 2018 | 230 | 0.120 |
Why?
| | Mast Cells | 2 | 2009 | 147 | 0.120 |
Why?
| | Hematopoietic Stem Cells | 3 | 1988 | 402 | 0.120 |
Why?
| | Cytotoxicity, Immunologic | 8 | 2010 | 225 | 0.120 |
Why?
| | History, 20th Century | 4 | 2016 | 324 | 0.120 |
Why?
| | Influenza A virus | 2 | 2013 | 110 | 0.120 |
Why?
| | Cerebroside-Sulfatase | 2 | 1993 | 3 | 0.120 |
Why?
| | Leukodystrophy, Metachromatic | 2 | 1993 | 3 | 0.120 |
Why?
| | T-Lymphocytes, Cytotoxic | 4 | 2011 | 173 | 0.110 |
Why?
| | Reactive Oxygen Species | 3 | 2003 | 621 | 0.110 |
Why?
| | RNA, Messenger | 11 | 2022 | 2831 | 0.110 |
Why?
| | Polymerase Chain Reaction | 7 | 2016 | 1059 | 0.110 |
Why?
| | Self Tolerance | 2 | 1996 | 28 | 0.110 |
Why?
| | Breast Neoplasms | 2 | 2018 | 2234 | 0.110 |
Why?
| | Interleukin-15 | 5 | 2006 | 97 | 0.110 |
Why?
| | Peptide Biosynthesis | 1 | 1994 | 13 | 0.110 |
Why?
| | Tumor Necrosis Factor-alpha | 6 | 2006 | 1242 | 0.110 |
Why?
| | Mutagenesis, Site-Directed | 3 | 2011 | 374 | 0.110 |
Why?
| | Receptors, Immunologic | 3 | 2020 | 216 | 0.110 |
Why?
| | Ribosomal Proteins | 1 | 2014 | 93 | 0.110 |
Why?
| | Mutagenesis | 3 | 2021 | 179 | 0.110 |
Why?
| | Cysteine | 2 | 2010 | 204 | 0.110 |
Why?
| | Granuloma | 1 | 2014 | 91 | 0.110 |
Why?
| | gamma-Globulins | 4 | 1983 | 18 | 0.100 |
Why?
| | Haplotypes | 4 | 1990 | 494 | 0.100 |
Why?
| | Antigens, CD | 5 | 2001 | 521 | 0.100 |
Why?
| | Immunity, Innate | 4 | 2021 | 825 | 0.100 |
Why?
| | Clonal Deletion | 4 | 2004 | 16 | 0.100 |
Why?
| | Nucleoproteins | 1 | 2013 | 29 | 0.100 |
Why?
| | Hydrogen Bonding | 2 | 2008 | 163 | 0.100 |
Why?
| | Sodium | 1 | 2014 | 216 | 0.100 |
Why?
| | Viral Proteins | 2 | 2009 | 340 | 0.100 |
Why?
| | Chimera | 8 | 2009 | 58 | 0.100 |
Why?
| | Gammaherpesvirinae | 1 | 2013 | 47 | 0.100 |
Why?
| | HLA Antigens | 4 | 2018 | 237 | 0.100 |
Why?
| | Antigen-Antibody Reactions | 7 | 2021 | 55 | 0.100 |
Why?
| | Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2012 | 26 | 0.100 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2013 | 81 | 0.100 |
Why?
| | Genes, Immunoglobulin | 3 | 1988 | 28 | 0.100 |
Why?
| | Diabetes Mellitus | 1 | 2021 | 1032 | 0.100 |
Why?
| | CD4 Antigens | 9 | 1998 | 142 | 0.100 |
Why?
| | Lymphocyte Depletion | 5 | 2001 | 135 | 0.100 |
Why?
| | Escherichia coli | 4 | 2013 | 806 | 0.100 |
Why?
| | Multiprotein Complexes | 1 | 2014 | 163 | 0.100 |
Why?
| | Models, Immunological | 4 | 2008 | 100 | 0.100 |
Why?
| | B7-1 Antigen | 3 | 2004 | 58 | 0.100 |
Why?
| | Chromosome Mapping | 8 | 2002 | 523 | 0.100 |
Why?
| | Antigens, Differentiation, B-Lymphocyte | 3 | 2013 | 37 | 0.090 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2012 | 126 | 0.090 |
Why?
| | Intestinal Mucosa | 1 | 1997 | 621 | 0.090 |
Why?
| | Dose-Response Relationship, Immunologic | 12 | 2000 | 82 | 0.090 |
Why?
| | Dermatitis, Allergic Contact | 1 | 2012 | 73 | 0.090 |
Why?
| | Communicable Diseases | 1 | 1994 | 159 | 0.090 |
Why?
| | Amino Acid Substitution | 3 | 2021 | 306 | 0.090 |
Why?
| | Sheep | 20 | 1983 | 856 | 0.090 |
Why?
| | Antilymphocyte Serum | 9 | 1981 | 64 | 0.090 |
Why?
| | Receptors, CXCR5 | 1 | 2011 | 21 | 0.090 |
Why?
| | Lipid A | 1 | 2011 | 29 | 0.090 |
Why?
| | Phagocytosis | 2 | 2011 | 379 | 0.090 |
Why?
| | Male | 30 | 2025 | 67313 | 0.090 |
Why?
| | Glycosylation | 4 | 1994 | 151 | 0.090 |
Why?
| | Molecular Conformation | 2 | 2009 | 145 | 0.090 |
Why?
| | Th1 Cells | 2 | 2010 | 143 | 0.090 |
Why?
| | Trypsin | 5 | 2006 | 77 | 0.090 |
Why?
| | Aluminum | 1 | 2010 | 42 | 0.080 |
Why?
| | Tumor Necrosis Factor Ligand Superfamily Member 15 | 1 | 2010 | 8 | 0.080 |
Why?
| | DNA, Recombinant | 4 | 2005 | 47 | 0.080 |
Why?
| | Crosses, Genetic | 7 | 2006 | 137 | 0.080 |
Why?
| | Immunization | 8 | 2004 | 411 | 0.080 |
Why?
| | Lymphocyte Count | 4 | 2010 | 150 | 0.080 |
Why?
| | Neoplasm Proteins | 1 | 2013 | 434 | 0.080 |
Why?
| | Gene Deletion | 2 | 2009 | 389 | 0.080 |
Why?
| | Complement C3 | 1 | 2011 | 209 | 0.080 |
Why?
| | Insulin-Secreting Cells | 2 | 2016 | 372 | 0.080 |
Why?
| | Epstein-Barr Virus Nuclear Antigens | 1 | 2009 | 10 | 0.080 |
Why?
| | DNA-Binding Proteins | 3 | 2014 | 1501 | 0.080 |
Why?
| | Chickens | 9 | 1994 | 191 | 0.080 |
Why?
| | Molecular Mimicry | 1 | 2009 | 42 | 0.080 |
Why?
| | Radiation Chimera | 6 | 2001 | 30 | 0.080 |
Why?
| | In Vitro Techniques | 8 | 2000 | 1089 | 0.080 |
Why?
| | Leukemia, Lymphoid | 3 | 2006 | 27 | 0.080 |
Why?
| | bcl-2 Homologous Antagonist-Killer Protein | 2 | 2006 | 15 | 0.080 |
Why?
| | Chronic Disease | 5 | 2021 | 1785 | 0.080 |
Why?
| | Molecular Docking Simulation | 2 | 2021 | 113 | 0.080 |
Why?
| | Histidine | 2 | 2003 | 64 | 0.080 |
Why?
| | Chromosomes, Human, X | 1 | 2010 | 73 | 0.080 |
Why?
| | HLA-B Antigens | 1 | 2009 | 62 | 0.080 |
Why?
| | Immunoglobulin Heavy Chains | 6 | 1988 | 83 | 0.080 |
Why?
| | Cell Membrane | 6 | 2004 | 735 | 0.080 |
Why?
| | Time Factors | 12 | 2013 | 6808 | 0.080 |
Why?
| | Macrophages, Peritoneal | 1 | 2009 | 94 | 0.080 |
Why?
| | Antibodies, Neutralizing | 2 | 2022 | 285 | 0.080 |
Why?
| | Mice, Inbred C3H | 7 | 1993 | 269 | 0.080 |
Why?
| | Immunity, Humoral | 2 | 2022 | 116 | 0.080 |
Why?
| | Sequence Alignment | 2 | 2008 | 342 | 0.080 |
Why?
| | Receptors, Interleukin-2 | 4 | 2003 | 66 | 0.080 |
Why?
| | RNA | 4 | 2010 | 921 | 0.080 |
Why?
| | Hydrogen-Ion Concentration | 3 | 2003 | 560 | 0.080 |
Why?
| | Fluorescent Dyes | 2 | 2001 | 317 | 0.080 |
Why?
| | Oligopeptides | 2 | 2001 | 271 | 0.080 |
Why?
| | Homeodomain Proteins | 1 | 2012 | 506 | 0.080 |
Why?
| | Proto-Oncogene Proteins c-cbl | 1 | 2008 | 12 | 0.080 |
Why?
| | Gonadal Steroid Hormones | 1 | 2010 | 140 | 0.070 |
Why?
| | DNA (Cytosine-5-)-Methyltransferases | 1 | 1988 | 31 | 0.070 |
Why?
| | Chondroitin | 1 | 1988 | 5 | 0.070 |
Why?
| | Ubiquitination | 1 | 2008 | 102 | 0.070 |
Why?
| | Mass Spectrometry | 3 | 2020 | 738 | 0.070 |
Why?
| | Lymphocytes | 6 | 1997 | 393 | 0.070 |
Why?
| | Mice, Inbred CBA | 8 | 2001 | 54 | 0.070 |
Why?
| | Receptors, Chemokine | 1 | 2008 | 47 | 0.070 |
Why?
| | Chondroitin Sulfates | 1 | 1988 | 32 | 0.070 |
Why?
| | Receptors, Tumor Necrosis Factor | 3 | 2003 | 164 | 0.070 |
Why?
| | Interleukin-6 | 3 | 2011 | 778 | 0.070 |
Why?
| | Herpesvirus 4, Human | 1 | 2009 | 167 | 0.070 |
Why?
| | Protein Domains | 2 | 2020 | 289 | 0.070 |
Why?
| | Interferon-beta | 2 | 2006 | 92 | 0.070 |
Why?
| | Protein Structure, Quaternary | 1 | 2008 | 125 | 0.070 |
Why?
| | Cell Movement | 5 | 2013 | 968 | 0.070 |
Why?
| | Galactosylceramides | 1 | 2007 | 25 | 0.070 |
Why?
| | Heterozygote | 2 | 2024 | 293 | 0.070 |
Why?
| | Oxidoreductases, N-Demethylating | 1 | 2007 | 16 | 0.070 |
Why?
| | Antigens, CD1d | 3 | 2013 | 68 | 0.070 |
Why?
| | Blotting, Western | 3 | 2020 | 1225 | 0.070 |
Why?
| | Gene Rearrangement, T-Lymphocyte | 2 | 2001 | 15 | 0.070 |
Why?
| | Recombinant Fusion Proteins | 5 | 2002 | 664 | 0.070 |
Why?
| | Interferon-alpha | 2 | 2006 | 198 | 0.070 |
Why?
| | Phenotype | 10 | 2008 | 3189 | 0.070 |
Why?
| | Open Reading Frames | 3 | 1992 | 119 | 0.070 |
Why?
| | Bone Marrow Cells | 3 | 2016 | 316 | 0.070 |
Why?
| | Sequence Homology, Nucleic Acid | 7 | 1992 | 155 | 0.070 |
Why?
| | Killer Cells, Natural | 2 | 2007 | 443 | 0.060 |
Why?
| | Molecular Structure | 2 | 2003 | 489 | 0.060 |
Why?
| | Poly I-C | 1 | 2006 | 63 | 0.060 |
Why?
| | Protein Biosynthesis | 3 | 1992 | 430 | 0.060 |
Why?
| | Restriction Mapping | 3 | 1998 | 77 | 0.060 |
Why?
| | Inflammation Mediators | 1 | 2009 | 513 | 0.060 |
Why?
| | Cell Culture Techniques | 3 | 2009 | 362 | 0.060 |
Why?
| | Chemotaxis, Leukocyte | 2 | 2003 | 139 | 0.060 |
Why?
| | Arginine | 2 | 2018 | 271 | 0.060 |
Why?
| | Moths | 3 | 1997 | 45 | 0.060 |
Why?
| | Bone Marrow | 4 | 2009 | 286 | 0.060 |
Why?
| | Proteins | 2 | 1982 | 1008 | 0.060 |
Why?
| | Hyaluronan Receptors | 3 | 2003 | 103 | 0.060 |
Why?
| | Jurkat Cells | 2 | 2009 | 134 | 0.060 |
Why?
| | Promoter Regions, Genetic | 4 | 2020 | 1249 | 0.060 |
Why?
| | Epithelium | 6 | 1997 | 311 | 0.060 |
Why?
| | Nitrophenols | 10 | 2004 | 34 | 0.060 |
Why?
| | Lipopolysaccharides | 8 | 2002 | 886 | 0.060 |
Why?
| | Proteolysis | 2 | 2018 | 177 | 0.060 |
Why?
| | Organ Culture Techniques | 6 | 1993 | 156 | 0.060 |
Why?
| | Oligonucleotides | 2 | 2004 | 148 | 0.060 |
Why?
| | Exons | 2 | 2000 | 351 | 0.060 |
Why?
| | Histiocytosis, Non-Langerhans-Cell | 1 | 2004 | 5 | 0.060 |
Why?
| | CD4-CD8 Ratio | 2 | 2002 | 22 | 0.060 |
Why?
| | Mice, Inbred A | 6 | 1984 | 49 | 0.050 |
Why?
| | Histocompatibility Antigen H-2D | 4 | 2010 | 21 | 0.050 |
Why?
| | Case-Control Studies | 3 | 2020 | 3540 | 0.050 |
Why?
| | Gene Library | 1 | 2004 | 116 | 0.050 |
Why?
| | Receptors, Leukotriene B4 | 1 | 2003 | 7 | 0.050 |
Why?
| | Phosphorylation | 4 | 2020 | 1758 | 0.050 |
Why?
| | Leukotriene B4 | 1 | 2003 | 42 | 0.050 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2004 | 139 | 0.050 |
Why?
| | CD28 Antigens | 2 | 2008 | 53 | 0.050 |
Why?
| | Luminescent Proteins | 2 | 2001 | 178 | 0.050 |
Why?
| | Microtubule-Associated Proteins | 1 | 2005 | 194 | 0.050 |
Why?
| | Selection, Genetic | 2 | 2019 | 264 | 0.050 |
Why?
| | Myeloid Cells | 1 | 2004 | 148 | 0.050 |
Why?
| | Genes, bcl-2 | 1 | 2002 | 21 | 0.050 |
Why?
| | Receptor-CD3 Complex, Antigen, T-Cell | 1 | 2002 | 9 | 0.050 |
Why?
| | Immunoblotting | 3 | 2008 | 306 | 0.050 |
Why?
| | Chemokine CCL5 | 1 | 2002 | 43 | 0.050 |
Why?
| | Talin | 1 | 2002 | 9 | 0.050 |
Why?
| | NF-kappa B | 2 | 2004 | 691 | 0.050 |
Why?
| | Anemia, Hemolytic, Autoimmune | 1 | 2002 | 14 | 0.050 |
Why?
| | Clodronic Acid | 1 | 2002 | 17 | 0.050 |
Why?
| | Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 2002 | 21 | 0.050 |
Why?
| | Serum Albumin, Bovine | 6 | 2011 | 63 | 0.050 |
Why?
| | Phosphoproteins | 1 | 2005 | 337 | 0.050 |
Why?
| | Leukocyte Common Antigens | 1 | 2002 | 87 | 0.050 |
Why?
| | Cardiopulmonary Resuscitation | 1 | 2025 | 249 | 0.050 |
Why?
| | Cell Fusion | 4 | 1989 | 51 | 0.050 |
Why?
| | Vaccines, Synthetic | 1 | 2022 | 126 | 0.050 |
Why?
| | Colorectal Neoplasms | 1 | 2010 | 791 | 0.050 |
Why?
| | Egg Proteins | 1 | 2001 | 17 | 0.050 |
Why?
| | Protein-Tyrosine Kinases | 2 | 2002 | 434 | 0.050 |
Why?
| | DNA, Viral | 1 | 2004 | 363 | 0.050 |
Why?
| | Genetic Vectors | 2 | 2001 | 317 | 0.050 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2002 | 92 | 0.050 |
Why?
| | Moloney murine leukemia virus | 1 | 2001 | 13 | 0.050 |
Why?
| | HIV Infections | 1 | 2016 | 2828 | 0.050 |
Why?
| | Sf9 Cells | 1 | 2021 | 9 | 0.050 |
Why?
| | Genotype | 4 | 2015 | 1914 | 0.050 |
Why?
| | Transduction, Genetic | 1 | 2001 | 126 | 0.040 |
Why?
| | Repetitive Sequences, Nucleic Acid | 2 | 1992 | 113 | 0.040 |
Why?
| | Receptors, Fc | 2 | 2020 | 53 | 0.040 |
Why?
| | Middle Aged | 6 | 2025 | 33228 | 0.040 |
Why?
| | Temperature | 2 | 2003 | 675 | 0.040 |
Why?
| | Borrelia burgdorferi Group | 1 | 2000 | 9 | 0.040 |
Why?
| | Sequence Analysis, DNA | 1 | 2004 | 809 | 0.040 |
Why?
| | Dimerization | 2 | 2001 | 198 | 0.040 |
Why?
| | Perissodactyla | 8 | 1981 | 12 | 0.040 |
Why?
| | Interleukin-1 | 5 | 1997 | 964 | 0.040 |
Why?
| | Cell Cycle Proteins | 1 | 2005 | 613 | 0.040 |
Why?
| | CD40 Antigens | 1 | 2001 | 89 | 0.040 |
Why?
| | Allergy and Immunology | 1 | 2001 | 43 | 0.040 |
Why?
| | Calcium | 6 | 2004 | 1197 | 0.040 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2004 | 428 | 0.040 |
Why?
| | Melanoma, Experimental | 1 | 2001 | 114 | 0.040 |
Why?
| | Adoptive Transfer | 4 | 2004 | 224 | 0.040 |
Why?
| | Models, Animal | 1 | 2002 | 384 | 0.040 |
Why?
| | Receptors, Virus | 1 | 2021 | 83 | 0.040 |
Why?
| | Netrin-1 | 1 | 2000 | 12 | 0.040 |
Why?
| | Survival Rate | 1 | 2025 | 1963 | 0.040 |
Why?
| | Biotinylation | 1 | 2000 | 32 | 0.040 |
Why?
| | Phorbol Esters | 1 | 2000 | 14 | 0.040 |
Why?
| | Immunoglobulin E | 2 | 2019 | 342 | 0.040 |
Why?
| | Expressed Sequence Tags | 1 | 2000 | 42 | 0.040 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 2001 | 130 | 0.040 |
Why?
| | Green Fluorescent Proteins | 3 | 2013 | 390 | 0.040 |
Why?
| | Aged | 4 | 2025 | 23794 | 0.040 |
Why?
| | Immune Sera | 5 | 1984 | 88 | 0.040 |
Why?
| | Haploidy | 1 | 1980 | 25 | 0.040 |
Why?
| | Calorimetry | 1 | 2000 | 70 | 0.040 |
Why?
| | Glucose Intolerance | 1 | 2021 | 146 | 0.040 |
Why?
| | Circular Dichroism | 1 | 2000 | 149 | 0.040 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2021 | 150 | 0.040 |
Why?
| | GTP Phosphohydrolases | 1 | 2000 | 93 | 0.040 |
Why?
| | Diet, High-Fat | 1 | 2021 | 247 | 0.040 |
Why?
| | B-Cell Activating Factor | 3 | 2006 | 21 | 0.040 |
Why?
| | Mitochondria | 2 | 2004 | 946 | 0.040 |
Why?
| | Lymphocytic choriomeningitis virus | 2 | 2011 | 24 | 0.040 |
Why?
| | Cytoskeletal Proteins | 1 | 2000 | 156 | 0.040 |
Why?
| | Protein Conformation, beta-Strand | 1 | 2019 | 17 | 0.040 |
Why?
| | Transcription Factor AP-1 | 1 | 2000 | 92 | 0.040 |
Why?
| | Hot Temperature | 2 | 2000 | 391 | 0.040 |
Why?
| | Receptors, Complement 3d | 1 | 2020 | 141 | 0.040 |
Why?
| | Homozygote | 2 | 1991 | 203 | 0.040 |
Why?
| | Biological Transport | 2 | 1999 | 416 | 0.040 |
Why?
| | Horses | 8 | 1981 | 111 | 0.040 |
Why?
| | Gene Knockout Techniques | 1 | 2020 | 117 | 0.040 |
Why?
| | Lipoproteins | 1 | 2000 | 168 | 0.040 |
Why?
| | Retroviridae | 2 | 2013 | 97 | 0.040 |
Why?
| | Vaccinia | 1 | 1999 | 21 | 0.040 |
Why?
| | MAP Kinase Kinase Kinases | 1 | 1999 | 73 | 0.040 |
Why?
| | Immunization, Secondary | 1 | 1999 | 89 | 0.040 |
Why?
| | Mice, Nude | 3 | 2013 | 696 | 0.040 |
Why?
| | Fibroblasts | 4 | 2017 | 993 | 0.040 |
Why?
| | Plasmids | 4 | 2001 | 360 | 0.040 |
Why?
| | Binding Sites, Antibody | 6 | 1991 | 42 | 0.040 |
Why?
| | Computer Simulation | 1 | 2003 | 973 | 0.040 |
Why?
| | fas Receptor | 4 | 2002 | 95 | 0.040 |
Why?
| | Trinitrobenzenes | 5 | 1982 | 14 | 0.040 |
Why?
| | Recombination, Genetic | 4 | 1988 | 200 | 0.040 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2006 | 975 | 0.040 |
Why?
| | DNA Repair | 1 | 2020 | 231 | 0.040 |
Why?
| | Cell Cycle | 2 | 2020 | 601 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2021 | 452 | 0.040 |
Why?
| | Rabbits | 6 | 1984 | 792 | 0.040 |
Why?
| | Precipitin Tests | 3 | 2001 | 100 | 0.040 |
Why?
| | Trans-Activators | 2 | 2000 | 398 | 0.040 |
Why?
| | Heparin | 1 | 2000 | 260 | 0.040 |
Why?
| | Coculture Techniques | 2 | 2013 | 239 | 0.040 |
Why?
| | Nucleosomes | 1 | 2020 | 155 | 0.040 |
Why?
| | Alternative Splicing | 1 | 2000 | 229 | 0.040 |
Why?
| | Intercellular Signaling Peptides and Proteins | 2 | 2013 | 382 | 0.040 |
Why?
| | Cartilage | 1 | 2000 | 188 | 0.040 |
Why?
| | Dogs | 1 | 2019 | 411 | 0.040 |
Why?
| | Asparagine | 1 | 1998 | 31 | 0.040 |
Why?
| | Hemoglobins | 2 | 2001 | 353 | 0.040 |
Why?
| | Crystallography | 2 | 2007 | 28 | 0.040 |
Why?
| | Interferon Type I | 1 | 1999 | 141 | 0.040 |
Why?
| | Codon | 1 | 1998 | 89 | 0.040 |
Why?
| | Receptors, Interferon | 2 | 2013 | 52 | 0.040 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 1978 | 41 | 0.040 |
Why?
| | Tumor Suppressor Proteins | 1 | 2000 | 327 | 0.030 |
Why?
| | Lupus Nephritis | 2 | 2006 | 63 | 0.030 |
Why?
| | Cricetinae | 3 | 1994 | 289 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2021 | 363 | 0.030 |
Why?
| | Immunoprecipitation | 2 | 2008 | 155 | 0.030 |
Why?
| | Caspases | 2 | 2014 | 247 | 0.030 |
Why?
| | MAP Kinase Signaling System | 1 | 1999 | 320 | 0.030 |
Why?
| | Collagen | 1 | 2000 | 446 | 0.030 |
Why?
| | Immunoglobulin Constant Regions | 3 | 1986 | 7 | 0.030 |
Why?
| | Age Factors | 4 | 2017 | 3284 | 0.030 |
Why?
| | Societies, Medical | 1 | 2001 | 816 | 0.030 |
Why?
| | Epithelial Cells | 2 | 2021 | 1094 | 0.030 |
Why?
| | Receptors, IgE | 1 | 1997 | 45 | 0.030 |
Why?
| | Phylogeny | 1 | 2021 | 903 | 0.030 |
Why?
| | Virus Diseases | 2 | 1992 | 213 | 0.030 |
Why?
| | Cats | 1 | 2017 | 209 | 0.030 |
Why?
| | Young Adult | 3 | 2020 | 13129 | 0.030 |
Why?
| | Germinal Center | 1 | 2017 | 58 | 0.030 |
Why?
| | Respiratory Hypersensitivity | 1 | 1997 | 69 | 0.030 |
Why?
| | Columbidae | 2 | 1994 | 31 | 0.030 |
Why?
| | Repressor Proteins | 1 | 2000 | 427 | 0.030 |
Why?
| | Chromatography, Gel | 3 | 2014 | 127 | 0.030 |
Why?
| | Drug Contamination | 1 | 2016 | 53 | 0.030 |
Why?
| | Emulsions | 1 | 2016 | 53 | 0.030 |
Why?
| | High-Throughput Screening Assays | 1 | 2018 | 158 | 0.030 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2016 | 99 | 0.030 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 1996 | 73 | 0.030 |
Why?
| | C-Peptide | 1 | 2016 | 163 | 0.030 |
Why?
| | Immunoconjugates | 1 | 1997 | 114 | 0.030 |
Why?
| | Hematopoiesis | 1 | 1997 | 190 | 0.030 |
Why?
| | Chemokine CCL19 | 1 | 2015 | 6 | 0.030 |
Why?
| | Chemokine CCL21 | 1 | 2015 | 14 | 0.030 |
Why?
| | Fetus | 3 | 1993 | 806 | 0.030 |
Why?
| | Immunoglobulin Isotypes | 2 | 2008 | 34 | 0.030 |
Why?
| | Receptors, CCR7 | 1 | 2015 | 32 | 0.030 |
Why?
| | Imidazoles | 1 | 2016 | 238 | 0.030 |
Why?
| | Adult | 6 | 2020 | 37631 | 0.030 |
Why?
| | Down-Regulation | 3 | 2003 | 656 | 0.030 |
Why?
| | Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 2 | 2012 | 21 | 0.030 |
Why?
| | Static Electricity | 1 | 2015 | 118 | 0.030 |
Why?
| | Tumor Cells, Cultured | 4 | 2001 | 953 | 0.030 |
Why?
| | Genes, T-Cell Receptor beta | 1 | 2014 | 22 | 0.030 |
Why?
| | Antibody Diversity | 3 | 1989 | 16 | 0.030 |
Why?
| | V(D)J Recombination | 1 | 2014 | 8 | 0.030 |
Why?
| | Immunophenotyping | 3 | 2004 | 319 | 0.030 |
Why?
| | Enzyme-Linked Immunospot Assay | 1 | 2014 | 36 | 0.030 |
Why?
| | Databases, Factual | 1 | 2000 | 1351 | 0.030 |
Why?
| | Cattle | 4 | 2011 | 981 | 0.030 |
Why?
| | Biological Transport, Active | 1 | 1994 | 77 | 0.030 |
Why?
| | Glutamic Acid | 2 | 2010 | 246 | 0.030 |
Why?
| | Early Growth Response Protein 2 | 1 | 2013 | 10 | 0.030 |
Why?
| | Chromatography, Ion Exchange | 1 | 2014 | 54 | 0.030 |
Why?
| | Culture Techniques | 2 | 1973 | 81 | 0.030 |
Why?
| | Lymphocyte Function-Associated Antigen-1 | 5 | 1999 | 31 | 0.030 |
Why?
| | Enzyme Activation | 3 | 2001 | 810 | 0.030 |
Why?
| | Endopeptidases | 1 | 1994 | 90 | 0.030 |
Why?
| | Golgi Apparatus | 1 | 1994 | 100 | 0.030 |
Why?
| | Receptors, Interleukin-7 | 2 | 2006 | 28 | 0.030 |
Why?
| | Forkhead Transcription Factors | 1 | 2014 | 190 | 0.030 |
Why?
| | Genetic Carrier Screening | 1 | 1993 | 28 | 0.030 |
Why?
| | Heparin-binding EGF-like Growth Factor | 1 | 2013 | 16 | 0.030 |
Why?
| | Thymectomy | 5 | 1975 | 15 | 0.030 |
Why?
| | Viral Envelope Proteins | 1 | 1994 | 84 | 0.030 |
Why?
| | Endopeptidase K | 1 | 2013 | 17 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2003 | 2052 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2025 | 10745 | 0.030 |
Why?
| | Growth Substances | 2 | 1983 | 147 | 0.030 |
Why?
| | Kidney | 2 | 2017 | 1467 | 0.030 |
Why?
| | HLA-DR Serological Subtypes | 1 | 2012 | 4 | 0.030 |
Why?
| | Adaptive Immunity | 1 | 2014 | 165 | 0.030 |
Why?
| | Interleukin-10 | 1 | 2015 | 302 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 2014 | 431 | 0.030 |
Why?
| | Antibodies, Viral | 1 | 2017 | 624 | 0.030 |
Why?
| | Prospective Studies | 1 | 2025 | 7572 | 0.020 |
Why?
| | Diphtheria Toxin | 1 | 2013 | 66 | 0.020 |
Why?
| | Minor Histocompatibility Antigens | 1 | 2013 | 48 | 0.020 |
Why?
| | Vomiting | 1 | 1993 | 130 | 0.020 |
Why?
| | Genes, MHC Class I | 2 | 2009 | 35 | 0.020 |
Why?
| | Epigenesis, Genetic | 1 | 2017 | 657 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 346 | 0.020 |
Why?
| | Dinoprostone | 2 | 1991 | 191 | 0.020 |
Why?
| | DNA Primers | 1 | 2013 | 514 | 0.020 |
Why?
| | Microsomes | 1 | 1992 | 33 | 0.020 |
Why?
| | DNA Restriction Enzymes | 3 | 1986 | 52 | 0.020 |
Why?
| | Zinc | 1 | 1995 | 297 | 0.020 |
Why?
| | Phosphotyrosine | 2 | 2002 | 39 | 0.020 |
Why?
| | Adolescent | 4 | 2016 | 21384 | 0.020 |
Why?
| | Immunoassay | 2 | 1989 | 113 | 0.020 |
Why?
| | Vinblastine | 3 | 1976 | 70 | 0.020 |
Why?
| | Nucleocapsid Proteins | 1 | 2011 | 24 | 0.020 |
Why?
| | Viral Core Proteins | 1 | 2011 | 21 | 0.020 |
Why?
| | Vaccinia virus | 2 | 2001 | 43 | 0.020 |
Why?
| | Child | 4 | 2016 | 21822 | 0.020 |
Why?
| | Resting Phase, Cell Cycle | 1 | 2011 | 15 | 0.020 |
Why?
| | Methionine | 1 | 1992 | 160 | 0.020 |
Why?
| | Receptors, Lymphocyte Homing | 1 | 2011 | 16 | 0.020 |
Why?
| | Mice, Inbred NZB | 2 | 2007 | 16 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2014 | 1316 | 0.020 |
Why?
| | Cell Adhesion | 3 | 1999 | 466 | 0.020 |
Why?
| | Cellular Senescence | 1 | 1993 | 187 | 0.020 |
Why?
| | Carbohydrates | 1 | 1991 | 65 | 0.020 |
Why?
| | Rosette Formation | 2 | 1980 | 16 | 0.020 |
Why?
| | Proteomics | 1 | 2018 | 1109 | 0.020 |
Why?
| | Rats | 5 | 2000 | 5639 | 0.020 |
Why?
| | Bone Marrow Transplantation | 2 | 1992 | 287 | 0.020 |
Why?
| | Salts | 1 | 2010 | 37 | 0.020 |
Why?
| | Minor Histocompatibility Loci | 1 | 1990 | 4 | 0.020 |
Why?
| | Mutant Chimeric Proteins | 1 | 2010 | 5 | 0.020 |
Why?
| | Orthomyxoviridae Infections | 1 | 2011 | 76 | 0.020 |
Why?
| | DNA, Bacterial | 1 | 1992 | 337 | 0.020 |
Why?
| | Depression, Chemical | 1 | 1990 | 23 | 0.020 |
Why?
| | Lysine | 1 | 2012 | 294 | 0.020 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2010 | 85 | 0.020 |
Why?
| | Milk | 1 | 1991 | 124 | 0.020 |
Why?
| | HLA-B8 Antigen | 1 | 2009 | 14 | 0.020 |
Why?
| | Immunodominant Epitopes | 1 | 2010 | 28 | 0.020 |
Why?
| | RNA, Double-Stranded | 1 | 2010 | 57 | 0.020 |
Why?
| | Epoprostenol | 1 | 1991 | 136 | 0.020 |
Why?
| | HLA-A Antigens | 1 | 2010 | 55 | 0.020 |
Why?
| | Nervous System Diseases | 1 | 1993 | 263 | 0.020 |
Why?
| | Fibrin | 1 | 2010 | 81 | 0.020 |
Why?
| | Fibrinogen | 1 | 2010 | 167 | 0.020 |
Why?
| | Thrombin | 1 | 2010 | 152 | 0.020 |
Why?
| | Injections, Intraperitoneal | 1 | 2009 | 115 | 0.020 |
Why?
| | Colonic Neoplasms | 1 | 2012 | 254 | 0.020 |
Why?
| | Chromosome Deletion | 4 | 1991 | 115 | 0.020 |
Why?
| | Antioxidants | 2 | 2003 | 584 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 2013 | 512 | 0.020 |
Why?
| | DNA, Single-Stranded | 1 | 2010 | 118 | 0.020 |
Why?
| | Immunoglobulin Class Switching | 1 | 2009 | 20 | 0.020 |
Why?
| | Immunoglobulin Joining Region | 1 | 1988 | 10 | 0.020 |
Why?
| | Deoxyribonuclease HpaII | 1 | 1988 | 2 | 0.020 |
Why?
| | Deoxyribonuclease BamHI | 1 | 1988 | 3 | 0.020 |
Why?
| | Deoxyribonucleases, Type II Site-Specific | 1 | 1988 | 15 | 0.020 |
Why?
| | Disulfides | 3 | 2003 | 107 | 0.020 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2011 | 250 | 0.020 |
Why?
| | Caspase 1 | 1 | 2009 | 143 | 0.020 |
Why?
| | Goats | 3 | 1973 | 27 | 0.020 |
Why?
| | Nedd4 Ubiquitin Protein Ligases | 1 | 2008 | 15 | 0.020 |
Why?
| | Phosphorylcholine | 1 | 1988 | 20 | 0.020 |
Why?
| | Integrin alpha4 | 1 | 2008 | 7 | 0.020 |
Why?
| | Cell Adhesion Molecules | 1 | 1990 | 181 | 0.020 |
Why?
| | Lymphocytic Choriomeningitis | 1 | 2008 | 14 | 0.020 |
Why?
| | Cell Nucleus | 2 | 1985 | 617 | 0.020 |
Why?
| | Transplantation Chimera | 1 | 2008 | 54 | 0.020 |
Why?
| | Endosomal Sorting Complexes Required for Transport | 1 | 2008 | 38 | 0.020 |
Why?
| | Genes, Switch | 1 | 1988 | 6 | 0.020 |
Why?
| | Genetic Engineering | 1 | 2009 | 91 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2020 | 7585 | 0.020 |
Why?
| | Eosinophils | 2 | 2004 | 332 | 0.020 |
Why?
| | Antigens, Helminth | 1 | 2008 | 12 | 0.020 |
Why?
| | Genes, Regulator | 1 | 1988 | 37 | 0.020 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2009 | 151 | 0.020 |
Why?
| | Schistosoma mansoni | 1 | 2008 | 37 | 0.020 |
Why?
| | Cross-Priming | 1 | 2008 | 18 | 0.020 |
Why?
| | Shock, Septic | 1 | 1990 | 219 | 0.020 |
Why?
| | Influenza Vaccines | 1 | 2013 | 537 | 0.020 |
Why?
| | Biosensing Techniques | 1 | 2009 | 122 | 0.020 |
Why?
| | Mannose | 1 | 1987 | 24 | 0.020 |
Why?
| | Hexosaminidases | 1 | 1987 | 18 | 0.020 |
Why?
| | Nitrobenzenes | 3 | 1976 | 13 | 0.020 |
Why?
| | Yersinia enterocolitica | 1 | 2007 | 7 | 0.020 |
Why?
| | Introns | 1 | 1988 | 256 | 0.020 |
Why?
| | Antigens, CD1 | 1 | 2007 | 58 | 0.020 |
Why?
| | Leukemia P388 | 2 | 1984 | 7 | 0.020 |
Why?
| | Fluoresceins | 2 | 2004 | 47 | 0.020 |
Why?
| | Infection Control | 1 | 2009 | 166 | 0.020 |
Why?
| | Oligosaccharides | 1 | 1987 | 60 | 0.020 |
Why?
| | Genetic Variation | 2 | 1990 | 985 | 0.020 |
Why?
| | RNA-Binding Proteins | 1 | 2011 | 423 | 0.020 |
Why?
| | Hypersensitivity, Delayed | 3 | 1978 | 28 | 0.020 |
Why?
| | Nucleic Acid Conformation | 1 | 2010 | 728 | 0.020 |
Why?
| | Pepsin A | 1 | 1986 | 19 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-jun | 1 | 2006 | 55 | 0.020 |
Why?
| | Immunologic Techniques | 2 | 1983 | 40 | 0.020 |
Why?
| | Antibodies, Antinuclear | 1 | 2006 | 71 | 0.020 |
Why?
| | Health | 1 | 2007 | 84 | 0.020 |
Why?
| | Oligonucleotides, Antisense | 2 | 2000 | 111 | 0.020 |
Why?
| | Weight Loss | 1 | 1992 | 776 | 0.020 |
Why?
| | Half-Life | 2 | 1977 | 164 | 0.020 |
Why?
| | Antigens, T-Independent | 2 | 1983 | 4 | 0.020 |
Why?
| | Proteinuria | 1 | 2006 | 97 | 0.020 |
Why?
| | Lymphoma | 5 | 1985 | 208 | 0.020 |
Why?
| | Transgenes | 2 | 1997 | 179 | 0.020 |
Why?
| | Leukopoiesis | 1 | 2006 | 11 | 0.020 |
Why?
| | Peptide Hydrolases | 1 | 2006 | 111 | 0.020 |
Why?
| | Kidney Glomerulus | 1 | 2006 | 114 | 0.020 |
Why?
| | Body Weight | 1 | 1990 | 985 | 0.010 |
Why?
| | Immunoenzyme Techniques | 1 | 1985 | 219 | 0.010 |
Why?
| | Guinea Pigs | 2 | 1977 | 158 | 0.010 |
Why?
| | Liposomes | 2 | 2002 | 220 | 0.010 |
Why?
| | Prostaglandins E | 1 | 1985 | 47 | 0.010 |
Why?
| | Drug Synergism | 2 | 1983 | 382 | 0.010 |
Why?
| | Succinimides | 1 | 2004 | 19 | 0.010 |
Why?
| | Cytoplasm | 1 | 1985 | 272 | 0.010 |
Why?
| | Protein Denaturation | 1 | 1984 | 74 | 0.010 |
Why?
| | Immunoglobulin Allotypes | 1 | 1984 | 9 | 0.010 |
Why?
| | Immunoglobulin Light Chains | 1 | 1984 | 47 | 0.010 |
Why?
| | Freund's Adjuvant | 1 | 2004 | 18 | 0.010 |
Why?
| | Interphase | 2 | 2000 | 32 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2004 | 271 | 0.010 |
Why?
| | B-Cell CLL-Lymphoma 10 Protein | 1 | 2004 | 2 | 0.010 |
Why?
| | Albumins | 1 | 1984 | 113 | 0.010 |
Why?
| | Genetic Markers | 1 | 1985 | 344 | 0.010 |
Why?
| | Immunoglobulins | 1 | 1984 | 171 | 0.010 |
Why?
| | Antigens, Differentiation | 2 | 1997 | 83 | 0.010 |
Why?
| | United States | 1 | 2001 | 14690 | 0.010 |
Why?
| | Isoelectric Focusing | 1 | 1983 | 34 | 0.010 |
Why?
| | Leukemia, Experimental | 1 | 1983 | 27 | 0.010 |
Why?
| | Sex Factors | 1 | 2010 | 2060 | 0.010 |
Why?
| | Macrophage-Activating Factors | 1 | 1983 | 4 | 0.010 |
Why?
| | Hemagglutination Tests | 2 | 1973 | 7 | 0.010 |
Why?
| | Catalase | 1 | 2003 | 130 | 0.010 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2004 | 152 | 0.010 |
Why?
| | Receptors, CCR5 | 1 | 2003 | 59 | 0.010 |
Why?
| | B-Cell Activation Factor Receptor | 1 | 2003 | 13 | 0.010 |
Why?
| | Nucleic Acid Hybridization | 2 | 1999 | 190 | 0.010 |
Why?
| | Lung Diseases | 1 | 2010 | 768 | 0.010 |
Why?
| | Fas Ligand Protein | 1 | 2003 | 59 | 0.010 |
Why?
| | Karyotyping | 1 | 1983 | 104 | 0.010 |
Why?
| | Birds | 1 | 1983 | 93 | 0.010 |
Why?
| | Incidence | 1 | 2010 | 2792 | 0.010 |
Why?
| | Neuropeptides | 1 | 2003 | 73 | 0.010 |
Why?
| | ZAP-70 Protein-Tyrosine Kinase | 1 | 2002 | 10 | 0.010 |
Why?
| | Lod Score | 1 | 2002 | 67 | 0.010 |
Why?
| | Prognosis | 1 | 1991 | 4013 | 0.010 |
Why?
| | Lymphocyte Culture Test, Mixed | 3 | 1990 | 50 | 0.010 |
Why?
| | Ubiquitin C | 1 | 2001 | 3 | 0.010 |
Why?
| | Graft Rejection | 1 | 1986 | 620 | 0.010 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2002 | 184 | 0.010 |
Why?
| | Sex Chromosome Aberrations | 1 | 1981 | 64 | 0.010 |
Why?
| | CD79 Antigens | 1 | 2001 | 15 | 0.010 |
Why?
| | Virus Assembly | 1 | 2002 | 77 | 0.010 |
Why?
| | Fetal Blood | 1 | 1983 | 327 | 0.010 |
Why?
| | Growth Inhibitors | 1 | 2001 | 43 | 0.010 |
Why?
| | Myoglobin | 1 | 2000 | 13 | 0.010 |
Why?
| | Organ Specificity | 1 | 2001 | 304 | 0.010 |
Why?
| | Genes, Reporter | 1 | 2001 | 268 | 0.010 |
Why?
| | Bacterial Proteins | 1 | 2007 | 873 | 0.010 |
Why?
| | Lyme Disease Vaccines | 1 | 2000 | 3 | 0.010 |
Why?
| | Neoplasm Transplantation | 1 | 2001 | 257 | 0.010 |
Why?
| | Sequence Analysis | 1 | 2000 | 36 | 0.010 |
Why?
| | Aspartic Acid | 1 | 2001 | 79 | 0.010 |
Why?
| | Up-Regulation | 1 | 2003 | 844 | 0.010 |
Why?
| | Biopolymers | 1 | 2000 | 31 | 0.010 |
Why?
| | Lymphocyte Subsets | 1 | 2000 | 87 | 0.010 |
Why?
| | Receptors, Interleukin-15 | 1 | 2000 | 3 | 0.010 |
Why?
| | Models, Biological | 2 | 2001 | 1773 | 0.010 |
Why?
| | Suppressor of Cytokine Signaling 1 Protein | 1 | 2000 | 12 | 0.010 |
Why?
| | Staining and Labeling | 2 | 1980 | 148 | 0.010 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2000 | 60 | 0.010 |
Why?
| | Bacterial Vaccines | 1 | 2000 | 63 | 0.010 |
Why?
| | Bacterial Outer Membrane Proteins | 1 | 2000 | 58 | 0.010 |
Why?
| | Suppressor of Cytokine Signaling Proteins | 1 | 2000 | 21 | 0.010 |
Why?
| | HLA-DRB1 Chains | 1 | 2000 | 112 | 0.010 |
Why?
| | Receptors, Interleukin-6 | 1 | 2000 | 43 | 0.010 |
Why?
| | Septins | 1 | 2000 | 43 | 0.010 |
Why?
| | In Situ Hybridization | 1 | 2000 | 316 | 0.010 |
Why?
| | MAP Kinase Kinase Kinase 2 | 1 | 1999 | 12 | 0.010 |
Why?
| | STAT1 Transcription Factor | 1 | 2000 | 73 | 0.010 |
Why?
| | Cell Lineage | 1 | 2001 | 347 | 0.010 |
Why?
| | GTP-Binding Proteins | 1 | 2000 | 161 | 0.010 |
Why?
| | Lyme Disease | 1 | 2000 | 60 | 0.010 |
Why?
| | Indicators and Reagents | 1 | 2000 | 106 | 0.010 |
Why?
| | Genes, Dominant | 1 | 1999 | 95 | 0.010 |
Why?
| | Child, Preschool | 2 | 1993 | 11000 | 0.010 |
Why?
| | Multigene Family | 2 | 1991 | 198 | 0.010 |
Why?
| | Lymphocyte Transfusion | 1 | 1999 | 21 | 0.010 |
Why?
| | Leukemia L1210 | 1 | 1999 | 8 | 0.010 |
Why?
| | Androstadienes | 1 | 1999 | 107 | 0.010 |
Why?
| | Lymphopenia | 1 | 1999 | 62 | 0.010 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 1999 | 162 | 0.010 |
Why?
| | Tissue Distribution | 2 | 1993 | 330 | 0.010 |
Why?
| | Free Radical Scavengers | 1 | 1999 | 88 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 1999 | 152 | 0.010 |
Why?
| | Manganese | 1 | 1999 | 62 | 0.010 |
Why?
| | Cholic Acids | 1 | 1998 | 18 | 0.010 |
Why?
| | Protein Isoforms | 1 | 2000 | 403 | 0.010 |
Why?
| | Detergents | 1 | 1998 | 44 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 1999 | 185 | 0.010 |
Why?
| | Metalloporphyrins | 1 | 1999 | 103 | 0.010 |
Why?
| | Absorption | 2 | 1975 | 63 | 0.010 |
Why?
| | Membrane Potentials | 1 | 1999 | 284 | 0.010 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 1999 | 283 | 0.010 |
Why?
| | STAT3 Transcription Factor | 1 | 2000 | 206 | 0.010 |
Why?
| | Polysaccharides, Bacterial | 2 | 1975 | 70 | 0.010 |
Why?
| | Nuclear Proteins | 1 | 2003 | 712 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 1999 | 313 | 0.010 |
Why?
| | Microscopy, Fluorescence | 1 | 1999 | 397 | 0.010 |
Why?
| | Histocompatibility | 1 | 1977 | 28 | 0.010 |
Why?
| | Isoantigens | 1 | 1977 | 15 | 0.010 |
Why?
| | Endocytosis | 1 | 1998 | 169 | 0.010 |
Why?
| | STAT6 Transcription Factor | 1 | 1997 | 27 | 0.010 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 1999 | 366 | 0.010 |
Why?
| | Hybridization, Genetic | 1 | 1978 | 77 | 0.010 |
Why?
| | Abatacept | 1 | 1997 | 53 | 0.010 |
Why?
| | Autoanalysis | 1 | 1977 | 8 | 0.010 |
Why?
| | Trypan Blue | 1 | 1977 | 6 | 0.010 |
Why?
| | Interleukins | 1 | 1999 | 250 | 0.010 |
Why?
| | Cytotoxicity Tests, Immunologic | 1 | 1977 | 41 | 0.010 |
Why?
| | Infant | 1 | 1991 | 9397 | 0.010 |
Why?
| | Gene Transfer Techniques | 1 | 1998 | 169 | 0.010 |
Why?
| | Whole-Body Irradiation | 1 | 1997 | 78 | 0.010 |
Why?
| | Warfarin | 1 | 1978 | 153 | 0.010 |
Why?
| | CTLA-4 Antigen | 1 | 1997 | 99 | 0.010 |
Why?
| | Genetic Complementation Test | 2 | 1986 | 66 | 0.010 |
Why?
| | Antigen-Antibody Complex | 2 | 1987 | 90 | 0.010 |
Why?
| | Enzyme Inhibitors | 1 | 1999 | 839 | 0.010 |
Why?
| | Immunity, Mucosal | 1 | 1997 | 97 | 0.010 |
Why?
| | Sequence Homology | 1 | 1995 | 40 | 0.010 |
Why?
| | Radiation Effects | 1 | 1975 | 7 | 0.010 |
Why?
| | Mollusca | 1 | 1975 | 6 | 0.010 |
Why?
| | Surface Properties | 1 | 1976 | 412 | 0.010 |
Why?
| | Trachea | 1 | 1997 | 237 | 0.010 |
Why?
| | Skin Tests | 1 | 1975 | 101 | 0.010 |
Why?
| | Methods | 1 | 1974 | 65 | 0.010 |
Why?
| | Complement System Proteins | 2 | 1974 | 327 | 0.010 |
Why?
| | Transferrin | 1 | 1993 | 46 | 0.010 |
Why?
| | Hindlimb | 1 | 1974 | 128 | 0.010 |
Why?
| | Umbilical Cord | 1 | 1994 | 85 | 0.010 |
Why?
| | Transplantation Immunology | 1 | 1993 | 34 | 0.010 |
Why?
| | Cell Transplantation | 1 | 1993 | 37 | 0.010 |
Why?
| | Viral Plaque Assay | 1 | 1973 | 31 | 0.010 |
Why?
| | Animals, Newborn | 2 | 1988 | 844 | 0.010 |
Why?
| | Immunoglobulin M | 1 | 1975 | 289 | 0.010 |
Why?
| | Bufo marinus | 1 | 1973 | 4 | 0.010 |
Why?
| | Antibodies, Anti-Idiotypic | 2 | 1983 | 59 | 0.010 |
Why?
| | Blotting, Southern | 1 | 1993 | 72 | 0.010 |
Why?
| | Fetal Tissue Transplantation | 1 | 1992 | 35 | 0.010 |
Why?
| | Pedigree | 1 | 1994 | 514 | 0.010 |
Why?
| | Macaca mulatta | 1 | 1993 | 166 | 0.010 |
Why?
| | Embryonic and Fetal Development | 1 | 1992 | 97 | 0.010 |
Why?
| | Models, Structural | 1 | 1991 | 40 | 0.010 |
Why?
| | Disease | 1 | 1993 | 98 | 0.010 |
Why?
| | Ionomycin | 1 | 1991 | 23 | 0.010 |
Why?
| | Oligodeoxyribonucleotides | 1 | 1992 | 143 | 0.010 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 1991 | 150 | 0.010 |
Why?
| | Liver | 2 | 1992 | 1940 | 0.010 |
Why?
| | DNA Methylation | 1 | 1996 | 640 | 0.010 |
Why?
| | 6-Ketoprostaglandin F1 alpha | 1 | 1991 | 21 | 0.010 |
Why?
| | Erythrocyte Transfusion | 1 | 1973 | 193 | 0.010 |
Why?
| | Calcimycin | 1 | 1991 | 49 | 0.010 |
Why?
| | Blotting, Northern | 1 | 1991 | 200 | 0.010 |
Why?
| | Endothelium, Vascular | 1 | 1997 | 926 | 0.010 |
Why?
| | Arthritis | 1 | 1991 | 95 | 0.010 |
Why?
| | Receptors, Leukocyte-Adhesion | 1 | 1990 | 5 | 0.010 |
Why?
| | Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 1990 | 8 | 0.010 |
Why?
| | Immunotherapy, Adoptive | 1 | 1993 | 321 | 0.010 |
Why?
| | Thymidine | 1 | 1970 | 60 | 0.010 |
Why?
| | Oligonucleotide Probes | 1 | 1990 | 51 | 0.010 |
Why?
| | RNA Splicing | 1 | 1991 | 268 | 0.010 |
Why?
| | Amidohydrolases | 1 | 1990 | 31 | 0.010 |
Why?
| | Cytosine | 1 | 1970 | 49 | 0.010 |
Why?
| | Carbon Isotopes | 1 | 1970 | 144 | 0.000 |
Why?
| | Cricetulus | 1 | 1989 | 109 | 0.000 |
Why?
| | Reference Values | 1 | 1990 | 816 | 0.000 |
Why?
| | Extracellular Space | 1 | 1989 | 119 | 0.000 |
Why?
| | Gestational Age | 1 | 1992 | 902 | 0.000 |
Why?
| | Cross-Linking Reagents | 1 | 1989 | 211 | 0.000 |
Why?
| | Microspheres | 1 | 1988 | 137 | 0.000 |
Why?
| | Bacteriophage lambda | 1 | 1988 | 88 | 0.000 |
Why?
| | Leukocyte Count | 1 | 1988 | 329 | 0.000 |
Why?
| | Adrenergic beta-Antagonists | 1 | 1970 | 323 | 0.000 |
Why?
| | Enhancer Elements, Genetic | 1 | 1988 | 190 | 0.000 |
Why?
| | Glass | 1 | 1986 | 45 | 0.000 |
Why?
| | Staphylococcal Infections | 1 | 1990 | 399 | 0.000 |
Why?
| | Immunoglobulin J-Chains | 1 | 1985 | 6 | 0.000 |
Why?
| | Mast-Cell Sarcoma | 1 | 1985 | 6 | 0.000 |
Why?
| | Transformation, Genetic | 1 | 1985 | 16 | 0.000 |
Why?
| | Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase | 1 | 1984 | 1 | 0.000 |
Why?
| | Liver Transplantation | 1 | 1992 | 871 | 0.000 |
Why?
| | Mesylates | 1 | 1984 | 7 | 0.000 |
Why?
| | Acetylglucosaminidase | 1 | 1984 | 5 | 0.000 |
Why?
| | Sezary Syndrome | 1 | 1984 | 44 | 0.000 |
Why?
| | Membranes, Artificial | 1 | 1984 | 72 | 0.000 |
Why?
| | Rats, Inbred Strains | 1 | 1984 | 362 | 0.000 |
Why?
| | Thymus Neoplasms | 1 | 1984 | 25 | 0.000 |
Why?
| | Isoelectric Point | 1 | 1984 | 25 | 0.000 |
Why?
| | Bacteria | 1 | 1991 | 854 | 0.000 |
Why?
| | Fixatives | 1 | 1983 | 15 | 0.000 |
Why?
| | Glutaral | 1 | 1983 | 16 | 0.000 |
Why?
| | Cell-Free System | 1 | 1983 | 53 | 0.000 |
Why?
| | Receptors, Antigen | 1 | 1983 | 16 | 0.000 |
Why?
| | Chemical Precipitation | 1 | 1983 | 37 | 0.000 |
Why?
| | Longitudinal Studies | 1 | 1990 | 2829 | 0.000 |
Why?
| | Tomography, X-Ray Computed | 1 | 1993 | 2667 | 0.000 |
Why?
| | X Chromosome | 1 | 1981 | 53 | 0.000 |
Why?
| | Brain | 1 | 1993 | 2664 | 0.000 |
Why?
| | Magnetic Resonance Imaging | 1 | 1993 | 3555 | 0.000 |
Why?
| | Pulmonary Alveoli | 1 | 1983 | 405 | 0.000 |
Why?
| | Polymers | 1 | 1983 | 488 | 0.000 |
Why?
| | Pregnancy | 1 | 1992 | 6726 | 0.000 |
Why?
| | Sarcoma, Experimental | 1 | 1974 | 7 | 0.000 |
Why?
| | Immunoglobulin Fragments | 1 | 1974 | 12 | 0.000 |
Why?
|
|
Kappler's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|